COST-EFFECTIVENESS ANALYSIS OF NEW ORAL ANTICOAGULANTS COMPARED TO WARFARIN IN THAI PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION

被引：1
|
作者：
Dilokthornsakul, P. [1 ]
Nathisuwan, S. [2 ]
Krittayaphong, R. [2 ]
Chutinet, A. [3 ]
Permsuwan, U. [4 ]
机构：
[1] Naresuan Univ, Muang, Phitsanulok, Thailand
[2] Mahidol Univ, Bangkok, Thailand
[3] King Chulalongkorn Mem Hosp, Chulalongkorn Stroke Ctr, Thai Red Cross Soc, Bangkok, Thailand
[4] Chiang Mai Univ, Chiang Mai, Thailand
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.07.234
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV40
引用
收藏
页码：S30 / S31
页数：2
相关论文
共 50 条
  • [21] New anticoagulants in patients with non-valvular atrial fibrillation
    Zellerhoff, S.
    Lewalter, T.
    Eckardt, L.
    Treszl, A.
    Wegscheider, K.
    Breithardt, G.
    [J]. NERVENHEILKUNDE, 2012, 31 (11) : 813 - 820
  • [22] Effect and risk of novel oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation
    Kawada, Tomoyuki
    [J]. JOURNAL OF CARDIOLOGY, 2017, 70 (1-2) : 99 - 99
  • [23] New oral anticoagulants for the prevention of stroke in patients with non-valvular atrial fibrillation
    Bosch, Montserrat
    Llop, Roser
    Lalueza, Pilar
    del Mar Villar, Maria
    [J]. MEDICINA CLINICA, 2013, 140 (05): : 229 - 231
  • [24] Indirect Comparisons of the New Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation
    Zolfaghari, Shabnam, Jr.
    Harenberg, Job
    Marx, Svetlana
    Wehling, Martin
    [J]. BLOOD, 2012, 120 (21)
  • [25] Cost-Effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation
    Coyle, Doug
    Coyle, Kathryn
    Cameron, Chris
    Lee, Karen
    Kelly, Shannon
    Steiner, Sabine
    Wells, George A.
    [J]. VALUE IN HEALTH, 2013, 16 (04) : 498 - 506
  • [26] Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients with polypharmacy
    Lip, Gregory Y. H.
    Keshishian, Allison
    Kang, Amiee
    Dhamane, Amol D.
    Luo, Xuemei
    Klem, Christian
    Rosenblatt, Lisa
    Mardekian, Jack
    Jiang, Jenny
    Yuce, Huseyin
    Deitelzweig, Steven
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (05) : 405 - 414
  • [27] COST-EFFECTIVENESS ANALYSIS OF PATIENT SELF-MANAGEMENT FOR MANAGING WARFARIN IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE US
    Kategeaw, W.
    King, J.
    Malone, D. C.
    Witt, D. M.
    Chaiyakunapruk, N.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S94 - S95
  • [28] Cost-effectiveness of apixaban compared to edoxaban for stroke prevention in non-valvular atrial fibrillation
    Lip, G. Y. H.
    Kongnakorn, T.
    Lanitis, T.
    Phatak, H.
    Liu, J. X. C.
    Kuznik, A.
    Lawrence, J.
    Dorian, P.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 1108 - 1109
  • [29] Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naive non-valvular atrial fibrillation patients in the US Department of defense population
    Gupta, Kiran
    Trocio, Jeffrey
    Keshishian, Allison
    Zhang, Qisu
    Dina, Oluwaseyi
    Mardekian, Jack
    Nadkarni, Anagha
    Shank, Thomas C.
    [J]. BMC CARDIOVASCULAR DISORDERS, 2019, 19 (1)
  • [30] COST-EFFECTIVENESS OF NEW ORAL ANTICOAGULANTS FOR PATIENTS WITH ATRIAL FIBRILLATION - A DECISION ANALYSIS
    You, J.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A285 - A286
12345